GlucoTrack, Inc.
GCTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $3 | $4 | $148 |
| - Cash | $8 | $10 | $9 | $6 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2 | -$6 | -$5 | $142 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$7 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$7 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | 4.64 | -9.62 | -0.67 | -21.75 |
| % Growth | 148.2% | -1,335.8% | 96.9% | – |
| Operating Cash Flow | – | -$4 | -$3 | -$3 |
| Capital Expenditures | – | $0 | -$0 | $0 |
| Free Cash Flow | – | -$4 | -$3 | -$3 |